Allergy and Asthma Patient Protection Act Introduced in Congress
The Allergy & Asthma Patient Protection Act would help address administrative and reimbursement issues that are unique to the allergy specialty.
The Allergy & Asthma Patient Protection Act would help address administrative and reimbursement issues that are unique to the allergy specialty.
The Allergy & Asthma Patient Protection Act would help address administrative and reimbursement issues that are unique to the allergy specialty.
Read MoreOmalizumab (Xolair) reduced reaction severity and eliminated the need for emergency epinephrine following food exposure.
Read MorePreemptive electrical power shutoffs intended to prevent wildfires are associated with increased emergency visits and hospitalizations, especially when smoke is present.
Read MoreLong-term use of acid reflux drugs may raise the risk of severe respiratory complications and emergency care visits for asthma patients treated with biologics.
Read MoreThe diabetes and weight loss injection semaglutide was associated with fewer asthma attacks and COPD exacerbations, according to ERS 2026 research.
Read MorePatients with severe asthma show structural brain changes and altered neural communication pathways linked to chronic inflammation.
Read MoreA high-dose vaccine reduced hospital admissions for flu or pneumonia by nearly 9% among older individuals with chronic respiratory conditions like asthma and COPD.
Read MoreA multiyear clinical trial found that OM-85 did not reduce severe wheezing episodes or early childhood asthma diagnoses.
Read MoreA clinical trial will evaluate a weekly dry powder nasal spray’s ability to boost natural defenses and prevent asthma infections.
Read MoreA hospital-based screening campaign identified significant gaps in asthma diagnosis and ongoing management among adults.
Read MoreResearchers used a new mapping method to find 21 genes that drive asthma biology, potentially revealing new targets for drug development.
Read MoreThe collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
Read MoreAstraZeneca’s triple-combination asthma therapy Breztri Aerosphere was approved in April 2026 for adults and pediatric patients age 12 and older.
Read MoreNew research suggests acoustic speech features can identify respiratory exacerbations from the first day of onset.
Read MoreA large-scale study finds that the introduction of asthma biologics in 2015 has led to immediate and sustained reductions in exacerbations at the population level.
Read MoreA collaboration between Jiva.ai and Aevice Health has developed a predictive model that identifies potential asthma exacerbations up to 72 hours in advance.
Read MoreResearch using lung-on-a-chip technology shows that mechanical stress from asthma attacks causes tissue damage independently of inflammation.
Read MoreResearchers suggest delivering vitamin D directly to the lungs could bypass the limitations of oral supplements in treating COPD and asthma.
Read MoreResearch involving more than 30,000 children suggests no link between household cats and asthma severity or lung function.
Read MoreThis article will provide 8 recommendations for effective patient education regarding inhaled medications used in treating/preventing asthma symptoms and flare-ups.
Read MoreA study of over 1.1 million American adults with asthma found that Black, Hispanic, and Asian patients use ICS, LABA and LAMA inhalers less frequently than white patients.
Read MoreA new study shows tezepelumab (Tezspire) reduced asthma exacerbations by 70% across all patient subgroups, including smokers and those with comorbid conditions.
Read MoreHigh consumption of ultra-processed food products significantly raises the likelihood of asthma onset in school-age children, according to a longitudinal study.
Read MoreOn World Asthma Day 2026, the American Thoracic Society and the Forum of International Respiratory Societies (FIRS) issued a call to action for universal access to anti-inflammatory inhalers.
Read More